One-year treatment with recombinant human growth hormone of children with meningomyelocele and growth hormone deficiency: A comparison of supine length and arm span

Journal of Pediatric Endocrinology and Metabolism

Volumn 12, Issue 2, 1999, Pages 153-159

  Hochhaus, Frederike ^a,c   Butenandt, O ^a   Ring Mrozik, Elfriede ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Department of Pediatric Surgery ^*  (Germany)

^c NONE   (Germany)

Author keywords

Growth hormone deficiency; Hydrocephalus; Meningomyelocele; rhGH treatment

Indexed keywords

GROWTH HORMONE; HUMAN GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ARTICLE; BODY HEIGHT; CHILD; CLINICAL ARTICLE; CONTRACTURE; FEMALE; GROWTH HORMONE DEFICIENCY; GROWTH RATE; GROWTH RETARDATION; HUMAN; KYPHOSCOLIOSIS; MALE; MENINGOMYELOCELE; NEURAL TUBE DEFECT; PRECOCIOUS PUBERTY; SHORT STATURE; SPASTICITY; SUBCUTANEOUS DRUG ADMINISTRATION; SUPINE POSITION; TREATMENT OUTCOME;

EID: 0032912708     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.1999.12.2.153     Document Type: Article

References (27)

1. Hayes-Allen MC. Obesity and short stature in children with meningomyelocele. Med Child Neurol 1972; 14: 59-64.
2. Green SA, Frank M, Zachmann M, Prader A. Growth and sexual developement in children with meningomyelocele. Eur J Pediatr 1985; 144: 146-148.
3. Perrone L, Del Gaizo D, D'Angelo E, Rea L, Di Manso G, Del Gado R. Endocrine Studies in children with meningomyelocele. J Pediatr Endocrinol 1994; 7: 219-223.
4. Rotenstein D, Breen T. Growth hormone treatment of children with myelomeningocele. J Pediatr 1996; 128: 28-31.
5. Klauschie J, Rose S. Incidence of short stature in children with hydrocephalus. J Pediatr Endocrinol Metab 1996; 9: 181-187.
6. Hochhaus F, Butenandt O, Schwarz HP, Ring-Mrozik E. Auxological and endocrinological evaluation of children with hydrocephalus and/or meningomyelocele. Eur J Pediatr 1997; 156: 597-601.
7. Trollmann R, Dörr HG, Strehl E, Katalinic A, Beyer R, Wenzel D. Growth and pubertal development in patients with meningomyelocele: a retrospective analysis. Acta Paediatr 1996; 85: 76-80.
8. Engstrom FM, Roche AF, Mukherjee D. Differences between arm span and stature in white children. J Adolesc Health Care 1981; 2-1: 19-22.
9. Miller F, Koreska J. Height measurement of patients with neuromuscular disease and contractures. Dev Med Child Neurol 1992; 34: 55-60.
10. Jarzem PF, Gledhill RB. Predicting height from arm span measurements. J Pediatr Orthop 1993; 13: 761-765.
11. Rosenblum MF, Finegold DN, Charney EB. Assessment of stature of children with meningomyelocele, and usefulness of arm span measurement. Dev Med Child Neurol 1983; 25: 338-342.
12. Belt-Neidbala BJ, Ekvall S, Cook CM, Oppenheimer S, Wessel J. Linear growth measurement: a comparison of single arm-lengths and arm-span. Dev Med Child Neurol 1986; 28: 319-324.
13. Rotenstein D, Reigel DH. Growth hormone treatment of children with neural tube defects: results from 6 months to 6 years. J Pediatr 1996; 128: 184-189.
14. Satin-Smith M, Levitt Katz L, Thornton P, Gruccio D, Moshang T. Arm span as measurement of response to growth hormone (GH) treatment in a group of children with meningomyelocele and GH deficiency. J Clin Endocrinol Metab 1996; 81: 1654-1656.
15. Flügel B, Greil H, Sommer K. Anthropologischer Atlas. Frankfurt/Man: Edition Wötzel, 1986; 110.
16. Prader A, Largo RH, Molinari L, Issler C. Physical growth of Swiss children from birth to 20 years of age. Helv Paediatr Acta 1989; Suppl 52: 94-95.
17. Tanner JM. Growth at Aldolescence. Oxford: Blackwell, 1962.
18. Greulich WW, Pyle SI. Radiographic Atlas of the Hand and Wrist. 2nd Ed. Stanford, CA: Standford University Press, 1959.
19. Rolland-Cachera MF, Cole TJ, Sempe M, Tichet J, Rossignol C, Charraud A. Body mass index variations: centiles from birth to 87 years. Eur J Clin Nutr 1991; 45: 13-71.
20. Shohat M, Tick D, Barakat S, Bu X, Melmed S, Rimoin DL. Short-term recombinant human growth hormone treatment increases growth rate in achondroplasia. J Clin Endocrinol Metab 1996; 81: 4033-4037.
21. Hochhaus F, Butenandt O, Schwarz HP, Ring-Mrozik E. Endocrinological disorders in children with shunted hydrocephalus. 10th International Congress of Endocrinology (ICE 1996), Program & Abstracts 1996; P1-452 p. 247.
22. Fujita K, Matuso M, Mori O, Koda N, Mukai E, Okabe Y, Shirakawa N, Tamai S, Itagane Y, Hibi I. The association of hypopituitarism with small pituitary, invisible pituitary stalk, type-1 Arnold-Chiari malformation and syringomyelia in seven patients born in breech position - A further proof for birth injury theory on the pathogenesis of idiopathic hypopituitarism. Eur J Pediatr 1992; 151: 266-270.
23. Hier DB, Wiehl AC. Chronic hydrocephalus associated with short stature and growth hormone deficiency. Ann Neurol 1977; 2: 246-248.
24. DuBoulay G, Trickey S. The sella in aqueduct stenosis and communicating hydrocephalus. Br J Radiol 1970; 43: 319-326.
25. Sartorio A, Narici MV. Growth hormone (GH) treatment in GH-deficient adults: effects on muscle size, strength and neural activation. Clin Physiol 1995; 14: 527-537.
26. Ogle GD, Rosenberg AR, Calligeros D, Kainer G. Effects of growth hormone treatment for short stature on calcium homeostasis, bone mineralisation, and body composition. Horm Res 1994; 41: 16-20.
27. Bengtsson BA, Brummer RJ, Eden S, Rosen T, Sjostrom L. Effects of growth hormone on fat mass and fat distribution. Acta Paediatr 1992; Suppl 383: 62-65.